Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs Nirwana Health

Direct Meds
Graded #19

Higher grade

vs+16.19999999999999
Nirwana Health
Graded #191

Lower grade

The verdict

Direct Meds takes it — 82.6/100 to 66.4/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDirect Meds +15
85
70
Dose & formulationDirect Meds +13
88
75
Clinical oversightDirect Meds +3
80
77
Labs & monitoringDirect Meds +26
78
52
FulfillmentDirect Meds +13
80
67
Contract termsDirect Meds +47
80
33
Direct Meds · left barNirwana Health · right bar

The numbers

MetricDirect MedsNirwana Health
WeighScore82.6/10066.4/100
GradeB−C
Scorecard rank#19#191
Semaglutide$179/mo$149/mo (compounded)
Tirzepatide$224/mo$229/mo (compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Direct Meds

Graded #19 · B−

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed
Nirwana Health

Graded #191 · C

Strengths

  • Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
  • Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
  • Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
  • Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
  • Also lists a retatrutide option and custom dosing plans for higher needs

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard